Lambda COVID-19 strain not yet a 'variant of concern,' says WHO | Inquirer News

Lambda COVID-19 strain not yet a ‘variant of concern,’ says WHO

/ 09:16 AM July 06, 2021

Two more cases of Delta variant infection logged in PH, says DOH

FILE PHOTO: Colorized scanning electron micrograph of an apoptotic cell (red) infected with SARS-COV-2 virus particles (yellow), also known as novel coronavirus, isolated from a patient sample. Image captured at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. National Institute of Allergy and Infectious Diseases, NIH/Handout via REUTERS.

MANILA, Philippines — The Lambda COVID-19 strain, feared to be “more infectious” than the Delta variant, remains to be a “variant of interest,” an official from the World Health Organization (WHO) said Tuesday.

“Lambda at this point in time still remains a variant of interest. That does not mean that we are not following it, we are still studying it and it doesn’t warrant a classification as a variant of concern at this point in time,” Dr. Rabindra Abeyasinghe, WHO representative to the Philippines, said in an interview on ABS-CBN News Channel.

Article continues after this advertisement

“It is present in several countries I believe, 20 to 30 countries now, but so far, it has not demonstrated characteristics that will warrant its classification as a variant of concern,” he added.

FEATURED STORIES

The Health Ministry of Malaysia earlier said that the Lambda variant was reported to have originated from Peru.

While the Lambda variant is feared to be “more infectious” than the Delta variant, Abeyasinghe said there is still not enough information to say that it is “more transmissible.”

Article continues after this advertisement

“We have multiple expert groups that start following that virus and studying that virus (variant), both within WHO and externally with our partners, so that we can better understand that virus (variant),” he also said.

“And if we see that the virus is more transmissible, is causing more severe disease, is resilient to the currently available therapeutics or vaccines, then we will decide to call it a variant of concern,” he added.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS:

No tags found for this post.
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.